Mutations in CHMP2B have been shown to cause ALS, FTD (with or without parkinsonism) and presenile dementia (Skibinski et al., 2005; Cannon et al., 2006; Parkinson et al., 2006; Cox et al., 2010). Here, CHMP2B is linked to Parkinson disease.